Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 705

1.

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.

Iuliani M, Pantano F, Buttigliero C, Fioramonti M, Bertaglia V, Vincenzi B, Zoccoli A, Ribelli G, Tucci M, Vignani F, Berruti A, Scagliotti GV, Tonini G, Santini D.

Oncotarget. 2015 Mar 30. [Epub ahead of print]

PMID:
25904051
2.

Trends in the early investigational drug development and areas for improvement.

Tonini G.

Expert Opin Investig Drugs. 2015 Apr 20:1-6. [Epub ahead of print]

PMID:
25891429
3.

Classic Kaposi Sarcoma: to treat or not to treat?

Vincenzi B, D'Onofrio L, Frezza AM, Grasso RF, Fausti V, Santini D, Dei Tos AP, Tonini G.

BMC Res Notes. 2015 Apr 10;8:138. doi: 10.1186/s13104-015-1076-1.

4.

Deregulation of dicer and mir-155 expression in liposarcoma.

Vincenzi B, Iuliani M, Zoccoli A, Pantano F, Fioramonti M, De Lisi D, Frezza AM, Rabitti C, Perrone G, Onetti Muda A, Russo A, Giordano A, Santini D, Dei Tos AP, Tonini G.

Oncotarget. 2015 Apr 4. [Epub ahead of print]

5.

The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?

Pantano F, Santoni M, Procopio G, Rizzo M, Iacovelli R, Porta C, Conti A, Lugini A, Milella M, Galli L, Ortega C, Guida FM, Silletta M, Schinzari G, Verzoni E, Modica D, Crucitti P, Rauco A, Felici A, Ballatore V, Cascinu S, Tonini G, Carteni G, Russo A, Santini D.

PLoS One. 2015 Apr 17;10(4):e0120427. doi: 10.1371/journal.pone.0120427. eCollection 2015.

6.

Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis.

Venditti O, De Lisi D, Caricato M, Caputo D, Capolupo GT, Taffon C, Pagliara E, Battisi S, Frezza AM, Onetti Muda A, Tonini G, Santini D.

BMC Cancer. 2015 Mar 1;15:87. doi: 10.1186/s12885-015-1074-7.

7.

Role of c-mesenchymal-epithelial transition pathway in gastric cancer.

Fioroni I, Dell'Aquila E, Pantano F, Intagliata S, Caricato M, Vincenzi B, Coppola R, Santini D, Tonini G.

Expert Opin Pharmacother. 2015 Apr 16:1-13. [Epub ahead of print]

PMID:
25881479
8.

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

Normanno N, Rachiglio AM, Lambiase M, Martinelli E, Fenizia F, Esposito C, Roma C, Troiani T, Rizzi D, Tatangelo F, Botti G, Maiello E, Colucci G, Ciardiello F; on the behalf of the CAPRI-GOIM investigators.

Ann Oncol. 2015 Apr 7. pii: mdv176. [Epub ahead of print]

PMID:
25851630
9.

Percutaneous Long Bone Cementoplasty for Palliation of Malignant Lesions of the Limbs: A Systematic Review.

Cazzato RL, Palussière J, Buy X, Denaro V, Santini D, Tonini G, Grasso RF, Zobel BB, Poretti D, Pedicini V, Balzarini L, Lanza E.

Cardiovasc Intervent Radiol. 2015 Mar 24. [Epub ahead of print]

PMID:
25799950
10.

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest.

Cremolini C, Loupakis F, Antoniotti C, Lonardi S, Masi G, Salvatore L, Cortesi E, Tomasello G, Spadi R, Zaniboni A, Tonini G, Barone C, Vitello S, Longarini R, Bonetti A, D'Amico M, Di Donato S, Granetto C, Boni L, Falcone A.

Ann Oncol. 2015 Feb 23. pii: mdv112. [Epub ahead of print]

PMID:
25712456
11.

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study.

De Tursi M, Carella C, Tomao S, Cinieri S, Lorusso V, Marchetti P, Vecchio S, Sansoni E, Contu A, Adamo V, Silvestris N, Nuzzo A, Rosti G, Ravaioli A, Danova M, Tonini G, Passalacqua R, Cruciani G, Faedi M, Spada M, De Laurentiis M, Amoroso D, Tomao F, Sperduti I, Grassadonia A, Tinari N, Natoli C, Iacobelli S; Consorzio Interuniversitario Nazionale per la Bio-Oncologia.

Tumori. 2014 Nov-Dec;100(6):e309-13. doi: 10.1700/1778.19310.

PMID:
25688518
12.

GH therapy in transition age: state of the art and future perspectives.

Cappa M, Caruso M, Saggese G, Salerno M, Tonini G.

Minerva Endocrinol. 2015 Mar;40(1):23-35.

PMID:
25660320
13.

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

Santoni M, Conti A, Procopio G, Porta C, Ibrahim T, Barni S, Guida FM, Fontana A, Berruti A, Berardi R, Massari F, Vincenzi B, Ortega C, Ottaviani D, Carteni G, Lanzetta G, De Lisi D, Silvestris N, Satolli MA, Collovà E, Russo A, Badalamenti G, Luzi Fedeli S, Tanca FM, Adamo V, Maiello E, Sabbatini R, Felici A, Cinieri S, Montironi R, Bracarda S, Tonini G, Cascinu S, Santini D.

J Exp Clin Cancer Res. 2015 Feb 5;34(1):10. doi: 10.1186/s13046-015-0122-0.

14.

Relapse and metastasis of atypical teratoid/rhabdoid tumor in a boy with neurofibromatosis type 1 treated with recombinant human growth hormone.

Tornese G, Faleschini E, Matarazzo L, Bibalo C, Zanazzo GA, Rabusin M, Tonini G, Zennaro F, Ventura A.

Neuropediatrics. 2015 Apr;46(2):126-9. doi: 10.1055/s-0034-1393706. Epub 2015 Jan 27.

PMID:
25625887
15.

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.

De Ferrari GM, Maier LS, Mont L, Schwartz PJ, Simonis G, Leschke M, Gronda E, Boriani G, Darius H, Guillamón Torán L, Savelieva I, Dusi V, Marchionni N, Quintana Rendón M, Schumacher K, Tonini G, Melani L, Giannelli S, Alberto Maggi C, John Camm A; RAFFAELLO Investigators (see Online Supplementary Appendix for List of Participating Centers and Investigators).

Heart Rhythm. 2015 Jan 17. pii: S1547-5271(15)00071-5. doi: 10.1016/j.hrthm.2015.01.021. [Epub ahead of print]

PMID:
25602175
16.

Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.

Della Pepa C, Tonini G, Santini D, Losito S, Pisano C, Di Napoli M, Cecere SC, Gargiulo P, Pignata S.

Cancer Treat Rev. 2015 Feb;41(2):136-43. doi: 10.1016/j.ctrv.2014.12.003. Epub 2014 Dec 23. Review.

PMID:
25573350
17.

Translational downregulation of HSP90 expression by iron chelators in neuroblastoma cells.

Sidarovich V, Adami V, Gatto P, Greco V, Tebaldi T, Tonini GP, Quattrone A.

Mol Pharmacol. 2015;87(3):513-24. doi: 10.1124/mol.114.095729. Epub 2015 Jan 6.

PMID:
25564462
18.

Ovarian cancer standard of care: are there real alternatives?

Della Pepa C, Tonini G, Pisano C, Di Napoli M, Cecere SC, Tambaro R, Facchini G, Pignata S.

Chin J Cancer. 2015 Jan 5;34(1):17-27. doi: 10.5732/cjc.014.10274.

19.

Onset of menstrual cycle and menses features among secondary school girls in Italy: A questionnaire study on 3,783 students.

De Sanctis V, Bernasconi S, Bianchin L, Bona G, Bozzola M, Buzi F, De Sanctis C, Rigon F, Tatò L, Tonini G, Perissinotto E.

Indian J Endocrinol Metab. 2014 Nov;18(Suppl 1):S84-92. doi: 10.4103/2230-8210.140251.

20.

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.

Rihani A, De Wilde B, Zeka F, Laureys G, Francotte N, Tonini GP, Coco S, Versteeg R, Noguera R, Schulte JH, Eggert A, Stallings RL, Speleman F, Vandesompele J, Van Maerken T.

PLoS One. 2014 Dec 11;9(12):e114696. doi: 10.1371/journal.pone.0114696. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk